114 related articles for article (PubMed ID: 12595587)
1. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease.
Yoshioka T; Matsutani T; Toyosaki-Maeda T; Suzuki H; Uemura S; Suzuki R; Koike M; Hinuma Y
Pediatr Res; 2003 Mar; 53(3):403-10. PubMed ID: 12595587
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.
Yoshioka T; Matsutani T; Iwagami S; Toyosaki-Maeda T; Yutsudo T; Tsuruta Y; Suzuki H; Uemura S; Takeuchi T; Koike M; Suzuki R
Immunology; 1999 Mar; 96(3):465-72. PubMed ID: 10233729
[TBL] [Abstract][Full Text] [Related]
3. Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease.
Masuda K; Takei S; Nomura Y; Imanaka H; Sameshima K; Yoshinaga M
Pediatr Res; 1998 Jul; 44(1):27-31. PubMed ID: 9667366
[TBL] [Abstract][Full Text] [Related]
4. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C.
Toyosaki T; Yoshioka T; Tsuruta Y; Yutsudo T; Iwasaki M; Suzuki R
Eur J Immunol; 1996 Nov; 26(11):2693-701. PubMed ID: 8921957
[TBL] [Abstract][Full Text] [Related]
5. Detection of multiple superantigen genes in stools of patients with Kawasaki disease.
Suenaga T; Suzuki H; Shibuta S; Takeuchi T; Yoshikawa N
J Pediatr; 2009 Aug; 155(2):266-70. PubMed ID: 19446844
[TBL] [Abstract][Full Text] [Related]
6. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
7. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age.
Nomura Y; Masuda K; Yoshinaga M; Takei S; Miyata K
Pediatr Infect Dis J; 2003 Sep; 22(9):794-8. PubMed ID: 14506370
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD).
Takata Y; Seki S; Dobashi H; Takeshita S; Nakatani K; Kamezawa Y; Hiraide H; Sekine I; Yoshioka S
Clin Exp Immunol; 1998 Nov; 114(2):311-9. PubMed ID: 9822292
[TBL] [Abstract][Full Text] [Related]
9. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
Morita A; Imada Y; Igarashi H; Yutsudo T
Microbiol Immunol; 1997; 41(11):895-900. PubMed ID: 9444333
[TBL] [Abstract][Full Text] [Related]
10. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
Norrby-Teglund A; Nepom GT; Kotb M
Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
[TBL] [Abstract][Full Text] [Related]
11. Clonal expansion of CD8+ T cells in Kawasaki disease.
Choi IH; Chwae YJ; Shim WS; Kim DS; Kwon DH; Kim JD; Kim SJ
J Immunol; 1997 Jul; 159(1):481-6. PubMed ID: 9200489
[TBL] [Abstract][Full Text] [Related]
12. TCR V beta family repertoire and T cell activation markers in Kawasaki disease.
Pietra BA; De Inocencio J; Giannini EH; Hirsch R
J Immunol; 1994 Aug; 153(4):1881-8. PubMed ID: 7913945
[TBL] [Abstract][Full Text] [Related]
13. Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.
Shiobara N; Suzuki Y; Aoki H; Gotoh A; Fujii Y; Hamada Y; Suzuki S; Fukui N; Kurane I; Itoh T; Suzuki R
Clin Exp Immunol; 2007 Oct; 150(1):13-21. PubMed ID: 17614973
[TBL] [Abstract][Full Text] [Related]
14. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.
Nomura Y; Yoshinaga M; Masuda K; Takei S; Miyata K
J Infect Dis; 2002 Jun; 185(11):1677-80. PubMed ID: 12023778
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
Gupta-Malhotra M; Viteri-Jackson A; Thomas W; Zabriskie JB
Exp Mol Pathol; 2004 Apr; 76(2):117-21. PubMed ID: 15010289
[TBL] [Abstract][Full Text] [Related]
16. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
17. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
Leung DY; Meissner C; Fulton D; Schlievert PM
J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).
Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B
J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222
[TBL] [Abstract][Full Text] [Related]
19. Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Age distribution in children and the relation to Kawasaki disease.
Abe Y; Nakano S; Nakahara T; Kamezawa Y; Kato I; Ushijima H; Yoshino K; Ito S; Noma S; Okitsu S
Pediatr Res; 1990 Jan; 27(1):11-5. PubMed ID: 2404253
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children.
Huang FY; Chang TY; Chen MR; Hsu CH; Lee HC; Lin SP; Kao HA; Chiu NC; Chi H; Liu TY; Liu HF; Dang CW; Chu CC; Lin M; Sung TC; Lee YJ
Hum Immunol; 2007 Jan; 68(1):69-74. PubMed ID: 17207714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
